VAERS reports by lot

GSK Hepatitis B lot H3SG9: VAERS reports

22 VAERS reports list lot H3SG9 as a GSK Hepatitis B vaccine, received between 2023-02-03 and 2024-12-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
22
Reports
0%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1435%
General / Systemic (non-local)820%
Gastrointestinal718%
Injection-site / Local reaction512%
Cardiac / Cardiovascular25%
Dermatological (non-injection-site)25%
Allergic / Anaphylactic12%
Musculoskeletal12%

Where reports came from

U.S. state of the reporter, where given (top 12).

California5
Texas2
Maine2
Pennsylvania1
Puerto Rico1
South Carolina1
North Carolina1
Florida1
Arkansas1
Georgia1
Wisconsin1
Massachusetts1

Reports by month received

2023-022
2023-037
2023-041
2023-051
2023-062
2023-072
2023-081
2023-111
2024-011
2024-031
2024-061
2024-091
2024-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.